Spyre Therapeutics, Inc. (SYRE): SCHEDULE 13G/A filed Aug 14, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 14, 2026

Accession number

0001493215-26-000157

Filer

Spyre Therapeutics, Inc. (CIK 1636282)